Medicaid still covers drugs not reviewed by the government–about $200 million worth since 2004, the Associated Press reports.
The medications, linked to dozens of deaths, are decades old. The Food and Drug Administration had less restrictive measures then and has tried, to no avail, to eliminate them from the market.
« Court approves Medicare freeze on payments to Miami home healthcare companies | Home | Medicare trust fund may shrink faster »
July 2, 2009
by: Andrea Kraynak, CPC-A • Auditing and assessment, Billing and reimbursement, Coding, Medicare compliance
June 26, 2009
by: Andrea Kraynak, CPC-A • Billing and reimbursement, Medicare compliance, RACs
July 2, 2009
by: Andrea Kraynak, CPC-A • Auditing and assessment, Medicaid
July 2, 2009
by: Patient Access Weekly Advisor • Auditing and assessment, Billing and reimbursement, Patient access
July 2, 2009
by: Case Management Weekly • Billing and reimbursement
July 2, 2009
by: Case Management Weekly • Auditing and assessment, case management
June 10, 2009
by: Andrea Kraynak, CPC-A • Medicare compliance, Popular
May 4, 2009
by: HIM Connection • Auditing and assessment, Billing and reimbursement, Coding, Popular
April 24, 2009
by: Andrea Kraynak, CPC-A • Auditing and assessment, Billing and reimbursement, Medicare compliance, Popular, RACs
April 23, 2009
by: Andrea Kraynak, CPC-A • Auditing and assessment, Billing and reimbursement, Coding, Medicare compliance, Popular
April 10, 2009
by: Andrea Kraynak, CPC-A • Billing and reimbursement, Medicare compliance, Popular, RACs
Leave a Comment